Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Embracing the Patient Voice Within Publications

    September 5, 2023 |  

    This whitepaper will explore multidisciplinary perspectives on how we can better engage patient communities in publications to optimize the value of their contributions, while navigating any uncertainties and reluctance from internal and external stakeholders.

    The biopharmaceutical sector continues to recognize the value of integrating the voice of the patient community into its activities.

    Despite growing recognition of the importance of patient partnership within publications, uncertainty remains regarding how best to involve patients and where in the process this involvement should happen. Furthermore, although many of our colleagues working in Medical Affairs and publications have established the goal of engaging patients in publications, possibly as authors, their own internal guidance on publication development may create roadblocks. Compliance and regulatory concerns can limit opportunities to partner with patient communities, and the occasional reluctance of physician authors to include patients as co-authors further exacerbates the situation. Additional barriers arise from the general uncertainty in the scientific communications community as to how and when to engage patients in an appropriate manner that ensures a positive experience and recognizes the resource challenges of advocacy groups.

    This paper will explore multidisciplinary perspectives on how we can better engage patient communities in publications to optimize the value of their contributions, while navigating any uncertainties and reluctance from internal and external stakeholders. We recognize that we are all learning together, with the shared goal of evolving our practices to fully embrace the voice of the patient while adhering to publication best practices and compliance. We welcome and encourage feedback from our industry colleagues to further refine our approaches.

    This article was originally published in our latest whitepaper “Embracing the Patient Voice Within Publications”. To learn more about the multidisciplinary perspectives on how to better engage patient communities in publications, read the full whitepaper.

    This content was provided by OPEN Health

    Company Details

    OPEN Health

    OPEN Health

    Email
    Website

     Latest Content from  OPEN Health 

    OPEN Health’s response to the FDA’s guidance on long term follow up post gene therapy

    Written by Gavin Jones, OPEN Health

    OPEN Health expands offering with the launch of a new Learning & Development specialist team

    Enhanced expertise to deliver impactful internal training programmes for healthcare clients

    Spotlight interview: 15 minutes on healthcare communications in gene therapy

    Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy

    OPEN Health becomes sponsor of MedComms Networking

    New for 2020, OPEN Health is pleased to announce its sponsorship of MedComms Networking

    OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications

    Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications

    Spotlight interview: 15 minutes on digital in medical communications

    Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications

    Generating data on long-term outcomes with gene and other advanced therapies

    Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’.

    Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?

    A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest....

    Spotlight interview: 15 minutes on insights and market research in pharma

    Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma

    OPEN Health reflections on the World Orphan Drug Congress in Barcelona

    Having just returned from a very busy but hugely enjoyable few days at congress, I wanted to share our views on the event and key themes that our healthcare communications...